Hematogenous and lymphatic tumor cell dissemination may be detected in patients diagnosed with ductal carcinoma in situ of the breast

Breast Cancer Research and Treatment

Volumn 131, Issue 3, 2012, Pages 801-808

  Banys, Malgorzata ^a   Gruber, Ines ^a   Krawczyk, Natalia ^a   Becker, Sven ^a   Kurth, Ralph ^b   Wallwiener, Diethelm ^a   Jakubowska, Jolanta ^a   Hoffmann, Jürgen ^a   Rothmund, Ralf ^a   Staebler, Annette ^b   Fehm, Tanja ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Breast cancer; Disseminated tumor cell; Ductal carcinoma in situ

Indexed keywords

CYTOKERATIN ANTIBODY;

ARTICLE; BONE MARROW; BONE MARROW BIOPSY; CANCER PATIENT; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GERMANY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INTRADUCTAL CARCINOMA; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TUMOR CELL; TUMOR VOLUME;

BONE MARROW; BREAST NEOPLASMS; CARCINOMA, INTRADUCTAL, NONINFILTRATING; FEMALE; HUMANS; INCIDENCE; LYMPH NODES; NEOPLASM METASTASIS; NEOPLASM STAGING;

EID: 84856233963     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-011-1478-2     Document Type: Article

References (40)

1. GH Sakorafas DR Farley G Peros 2008 Recent advances and current controversies in the management of DCIS of the breast Cancer Treat Rev 34 6 483 497 18490111 10.1016/j.ctrv.2008.03.001 1:CAS:528:DC%2BD1cXhtV2is7%2FM
2. VL Ernster R Ballard-Barbash WE Barlow Y Zheng DL Weaver G Cutter BC Yankaskas R Rosenberg PA Carney K Kerlikowske SH Taplin N Urban BM Geller 2002 Detection of ductal carcinoma in situ in women undergoing screening mammography J Natl Cancer Inst 94 20 1546 1554 12381707 10.1093/jnci/94.20.1546
3. VL Ernster J Barclay K Kerlikowske D Grady C Henderson 1996 Incidence of and treatment for ductal carcinoma in situ of the breast JAMA 275 12 913 918 8598618 10.1001/jama.1996.03530360023033 1:STN:280:DyaK287nvVOmtA%3D%3D
4. VL Ernster J Barclay K Kerlikowske H Wilkie R Ballard-Barbash 2000 Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program Arch Intern Med 160 7 953 958 10761960 10.1001/archinte.160.7.953 1:STN:280: DC%2BD3c3it1GqtQ%3D%3D
5. TA Kelly JA Kim R Patrick S Grundfest JP Crowe 2003 Axillary lymph node metastases in patients with a final diagnosis of ductal carcinoma in situ Am J Surg 186 4 368 370 14553852 10.1016/S0002-9610(03)00276-9
6. M Intra N Rotmensz P Veronesi M Colleoni S Iodice G Paganelli G Viale U Veronesi 2008 Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years Ann Surg 247 2 315 319 18216539 10.1097/SLA.0b013e31815b446b
7. Y Husemann JB Geigl F Schubert P Musiani M Meyer E Burghart G Forni R Eils T Fehm G Riethmuller CA Klein 2008 Systemic spread is an early step in breast cancer Cancer Cell 13 1 58 68 18167340 10.1016/j.ccr.2007.12.003
8. CA Klein 2009 Parallel progression of primary tumours and metastases Nat Rev Cancer 9 4 302 312 19308069 10.1038/nrc2627 1:CAS:528:DC%2BD1MXjsFSrsr8%3D
9. K Jamshidi WR Swaim 1971 Bone marrow biopsy with unaltered architecture: a new biopsy device J Lab Clin Med 77 2 335 342 5540776 1:STN:280: DyaE3M%2Fpt1emtw%3D%3D
10. T Fehm S Braun V Muller W Janni G Gebauer C Marth C Schindlbeck D Wallwiener E Borgen B Naume K Pantel E Solomayer 2006 A concept for the standardized detection of disseminated tumor cells in bone marrow from patients with primary breast cancer and its clinical implementation Cancer 107 5 885 892 16874814 10.1002/cncr.22076
11. KD Bauer J de la Torre-Bueno IJ Diel D Hawes WJ Decker C Priddy B Bossy S Ludmann K Yamamoto AS Masih FP Espinoza DS Harrington 2000 Reliable and sensitive analysis of occult bone marrow metastases using automated cellular imaging Clin Cancer Res 6 9 3552 3559 10999743 1:STN:280:DC%2BD3cvkslWksw%3D%3D
12. E Borgen B Naume JM Nesland G Kvalheim K Beiske O Fodstad IJ Diel EF Solomayer P Theocharous RC Coombes BM Smith E Wunder J-P Marolleau J Garci K Pantel 1999 Standardization of the immunocytochemical detection of cancer cells in BM and blood I establishment of objective criteria for the evaluation of immunostained cells Cytotherapy 1 5 377 388 20426539 10.1080/0032472031000141283 1:STN:280:DC%2BC3c3ps1Cjtw%3D%3D
13. LM McShane DG Altman W Sauerbrei SE Taube M Gion GM Clark 2006 Reporting recommendations for tumor marker prognostic studies (REMARK) Breast Cancer Res Treat 100 2 229 235 16932852 10.1007/s10549-006-9242-8
14. SR Wellings HM Jensen 1973 On the origin and progression of ductal carcinoma in the human breast J Natl Cancer Inst 50 5 1111 1118 4123242 1:STN:280:DyaE3s3gt1Cjuw%3D%3D
15. AC Broders 1932 Carcinoma in situ contrasted with benign penetrating epithelium JAMA 99 1670 1674 10.1001/jama.1932.02740720024007
16. JC Bloodgood 1931 Border-line breast tumors Ann Surg 93 235 249 17866469 10.1097/00000658-193101000-00033 1:STN:280:DC%2BD2srltFGitw%3D%3D
17. K Chin CO de Solorzano D Knowles A Jones W Chou EG Rodriguez WL Kuo BM Ljung K Chew K Myambo M Miranda S Krig J Garbe M Stampfer P Yaswen JW Gray SJ Lockett 2004 In situ analyses of genome instability in breast cancer Nat Genet 36 9 984 988 15300252 10.1038/ng1409 1:CAS:528:DC%2BD2cXntFSkurg%3D
18. B Cutuli C Cohen-Solal-Le Nir B De Lafontan H Mignotte V Fichet R Fay V Servent S Giard C Charra-Brunaud H Auvray F Penault-Llorca JC Charpentier 2001 Ductal carcinoma in situ of the breast results of conservative and radical treatments in 716 patients Eur J Cancer 37 18 2365 2372 11720829 10.1016/S0959-8049(01)00303-3 1:STN:280:DC%2BD3MnnsV2msg%3D%3D
19. JF Lara SM Young RE Velilla EJ Santoro SF Templeton 2003 The relevance of occult axillary micrometastasis in ductal carcinoma in situ: a clinicopathologic study with long-term follow-up Cancer 98 10 2105 2113 14601079 10.1002/cncr.11761
20. DL Weaver 2003 Occult "micrometastases" in ductal carcinoma in situ: investigative implications for sentinel lymph node biopsy Cancer 98 10 2083 2087 14601075 10.1002/cncr.11762
21. CH van Deurzen MG Hobbelink R van Hillegersberg PJ van Diest 2007 Is there an indication for sentinel node biopsy in patients with ductal carcinoma in situ of the breast? A review Eur J Cancer 43 6 993 1001 17300928 10.1016/j.ejca.2007.01.010
22. CE Cox K Nguyen RJ Gray C Salud NN Ku E Dupont L Hutson E Peltz G Whitehead D Reintgen A Cantor 2001 Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS? Am Surg 67 6 513 519 11409797 1:STN:280:DC%2BD3MzkslSnsQ%3D%3D discussion 519-521
23. TW Yen KK Hunt MI Ross NQ Mirza GV Babiera F Meric-Bernstam SE Singletary WF Symmans SH Giordano BW Feig FC Ames HM Kuerer 2005 Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ J Am Coll Surg 200 4 516 526 15804465 10.1016/j.jamcollsurg. 2004.11.012
24. SM Feldman DN Krag RK McNally BB Moor DL Weaver P Klein 1999 Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy J Am Coll Surg 188 3 248 254 10065813 10.1016/S1072-7515(98)00306-8 1:STN:280:DyaK1M7mtlKqtA%3D%3D
25. GH Lyman AE Giuliano MR Somerfield AB Benson 3rd DC Bodurka HJ Burstein AJ Cochran HS Cody 3rd SB Edge S Galper JA Hayman TY Kim CL Perkins DA Podoloff VH Sivasubramaniam RR Turner R Wahl DL Weaver AC Wolff EP Winer 2005 American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer J Clin Oncol 23 30 7703 7720 16157938 10.1200/JCO.2005.08.001
26. S Friberg S Mattson 1997 On the growth rates of human malignant tumors: implications for medical decision making J Surg Oncol 65 4 284 297 9274795 10.1002/(SICI)1096-9098(199708)65:4<284::AID-JSO11>3.0.CO;2-2 1:STN:280:DyaK2svhvVOiuw%3D%3D
27. O Schmidt-Kittler T Ragg A Daskalakis M Granzow A Ahr TJ Blankenstein M Kaufmann J Diebold H Arnholdt P Muller J Bischoff D Harich G Schlimok G Riethmuller R Eils CA Klein 2003 From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression Proc Natl Acad Sci USA 100 13 7737 7742 12808139 10.1073/pnas.1331931100 1:CAS:528:DC%2BD3sXlt1Wqs7s%3D
28. J Engel R Eckel J Kerr M Schmidt G Furstenberger R Richter H Sauer HJ Senn D Holzel 2003 The process of metastasisation for breast cancer Eur J Cancer 39 12 1794 1806 12888376 10.1016/S0959-8049(03)00422-2 1:STN:280: DC%2BD3szlsFCmtQ%3D%3D
29. T Fehm N Krawczyk EF Solomayer G Becker-Pergola S Durr-Storzer H Neubauer H Seeger A Staebler D Wallwiener S Becker 2008 ER alpha-status of disseminated tumour cells in bone marrow of primary breast cancer patients Breast Cancer Res 10 5 R76 18793387 10.1186/bcr2143
30. N Krawczyk M Banys H Neubauer EF Solomayer C Gall M Hahn S Becker R Bachmann D Wallwiener T Fehm 2009 HER2 status on persistent disseminated tumor cells after adjuvant therapy may differ from initial HER2 status on primary tumor Anticancer Res 29 10 4019 4024 19846945
31. K Podsypanina YC Du M Jechlinger LJ Beverly D Hambardzumyan H Varmus 2008 Seeding and propagation of untransformed mouse mammary cells in the lung Science 321 5897 1841 1844 18755941 10.1126/science.1161621 1:CAS:528: DC%2BD1cXhtFCrtLrI
32. M Intra P Veronesi G Mazzarol V Galimberti A Luini V Sacchini G Trifiro O Gentilini G Pruneri P Naninato F Torres G Paganelli G Viale U Veronesi 2003 Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast Arch Surg 138 3 309 313 12611580 10.1001/archsurg.138.3.309
33. H Mabry AE Giuliano MJ Silverstein 2006 What is the value of axillary dissection or sentinel node biopsy in patients with ductal carcinoma in situ? Am J Surg 192 4 455 457 16978948 10.1016/j.amjsurg.2006.06.028
34. A Katz I Gage S Evans M Shaffer T Fleury FP Smith R Flax C Drogula P Petrucci C Magnant 2006 Sentinel lymph node positivity of patients with ductal carcinoma in situ or microinvasive breast cancer Am J Surg 191 6 761 766 16720145 10.1016/j.amjsurg.2006.01.019
35. G Zavagno P Carcoforo R Marconato Z Franchini G Scalco P Burelli P Pietrarota M Lise R Mencarelli G Capitanio A Ballarin ME Pierobon G Marconato D Nitti 2005 Role of axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast BMC Cancer 5 28 15762990 10.1186/1471-2407-5-28
36. S Pendas E Dauway R Giuliano N Ku CE Cox DS Reintgen 2000 Sentinel node biopsy in ductal carcinoma in situ patients Ann Surg Oncol 7 1 15 20 10674443 10.1007/s10434-000-0015-z 1:STN:280:DC%2BD3c7js12jug%3D%3D
37. N Klauber-DeMore LK Tan L Liberman S Kaptain J Fey P Borgen A Heerdt L Montgomery M Paglia JA Petrek HS Cody KJ Van Zee 2000 Sentinel lymph node biopsy: is it indicated in patients with high-risk ductal carcinoma-in situ and ductal carcinoma-in situ with microinvasion? Ann Surg Oncol 7 9 636 642 11034239 10.1007/s10434-000-0636-2 1:STN:280:DC%2BD3cvosFGkuw%3D%3D
38. M Leidenius K Salmenkivi K von Smitten P Heikkila 2006 Tumour-positive sentinel node findings in patients with ductal carcinoma in situ J Surg Oncol 94 5 380 384 16967467 10.1002/jso.20581 1:STN:280:DC%2BD28rlsVygtw%3D%3D
39. R Sakr E Barranger M Antoine H Prugnolle E Darai S Uzan 2006 Ductal carcinoma in situ: value of sentinel lymph node biopsy J Surg Oncol 94 5 426 430 16967457 10.1002/jso.20578
40. S Di Saverio F Catena D Santini L Ansaloni T Fogacci S Mignani A Leone F Gazzotti S Gagliardi A De Cataldis M Taffurelli 2008 259 Patients with DCIS of the breast applying USC/Van Nuys Prognostic Index: a retrospective review with long term follow up Breast Cancer Res Treat 109 3 405 416 17687650 10.1007/s10549-007-9668-7